About this trial
The VASCULAID-RETRO study, within the broader VASCULAID project, aims to create artificial intelligence (AI) algorithms that can predict cardiovascular events and the progression of abdominal aortic aneurysm (AAA) and peripheral arterial disease (PAD). The study plans to gather and analyze data from at least 5000 AAA and 6000 PAD patients, combining existing cohorts and retrospectively collected data. During this project, AI tools will be developed to perform automatic anatomical segmentation and analyses on multimodal imaging. AI prediction algorithms will be developed based on multisource data (imaging, medical history, -omics).
Eligibility criteria
Qualifiers
Males and females, 40-90 years old, with an AAA >3cm. This includes patients with infrarenal, juxtarenal, suprarenal, iliac (defined as 1.5x its normal diameter) aneurysms, as well as mycotic aneurysms. Patients that have had interventions or ruptures will also be included
Males and females, 40-90 years old, all PAD patients (Fontaine stages 1,2,3, and 4).
Disqualifiers
Patients with an ascending, thoracic, thoracoabdominal (type 1-3) aneurysm.
Trial design
Treatments tested in this trial
- No intervention, retrospective study
Treatment groups
Sponsors and collaborators
Amsterdam UMC, location VUmc
Lead sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Collaborator
Technical University of Twente
Collaborator
Universidade do Porto
Collaborator
Centre Hospitalier Universitaire de Nice
Collaborator
Stichting Allai
Collaborator
University of Belgrade
Collaborator
Brightfish Be
Collaborator
Hospital District of Helsinki and Uusimaa
Collaborator
University of Bergen
Collaborator
Asklepios Kliniken Hamburg GmbH
Collaborator
University of Oxford
Collaborator
VINČA INSTITUTE OF NUCLEAR SCIENCES Belgrado
Collaborator